×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Editas Medicine Earnings Date, Estimates & Call Transcripts (2022)

$12.59
+0.76 (+6.42%)
(As of 07/1/2022 05:43 PM ET)
Add
Compare
Today's Range
$11.79
$12.68
50-Day Range
$9.99
$15.81
52-Week Range
$9.59
$73.03
Volume
1.44 million shs
Average Volume
1.81 million shs
Market Capitalization
$864.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.20

Earnings Summary

Upcoming
Earnings Date
Aug. 3Estimated
Actual EPS
(May. 4)
-$0.74 Beat By $0.07
Consensus EPS
(May. 4)
-$0.81
Last Year's Q2 EPS
(5/5/2021)
-$0.86
Skip Charts & View Estimated and Actual Earnings Data

EDIT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EDIT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Editas Medicine Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.82)($0.82)($0.82)
Q2 20223($0.89)($0.72)($0.83)
Q3 20223($0.88)($0.77)($0.84)
Q4 20223($0.96)($0.62)($0.83)
FY 202210($3.55)($2.93)($3.32)

EDIT Earnings Date and Information

Editas Medicine last issued its quarterly earnings results on May 4th, 2022. The reported ($0.74) earnings per share for the quarter, beating the consensus estimate of ($0.81) by $0.07. The company earned $6.80 million during the quarter, compared to analyst estimates of $3.85 million. Its revenue for the quarter was up 4.6% compared to the same quarter last year. Editas Medicine has generated ($2.73) earnings per share over the last year (($2.73) diluted earnings per share). Earnings for Editas Medicine are expected to grow in the coming year, from ($3.41) to ($3.38) per share. Editas Medicine has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 3rd, 2022 based off prior year's report dates.

Editas Medicine Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/3/2022
(Estimated)
        
5/4/2022Q1 2022($0.81)($0.74)+$0.07($0.74)$3.85 million$6.80 million    
2/24/2022Q4 2021($0.78)($0.61)+$0.17($0.61)$4.70 million$12.50 million    
11/8/20219/30/2021($0.81)($0.57)+$0.24($0.57)$4.92 million$6.20 million    
8/4/20216/30/2021($0.85)($0.81)+$0.04($0.81)$6.78 million$0.38 million    
5/5/20213/31/2021($0.76)($0.86)($0.10)($0.86)$5.78 million$6.50 million  
2/25/202112/31/2020($0.81)($1.00)($0.19)($1.00)$5.64 million$11.42 million  
11/5/20209/30/2020($0.66)$0.12+$0.78$0.12$6.36 million$62.84 million  
8/6/2020Q2 2020($0.80)($0.43)+$0.37($0.43)$6.34 million$10.75 million  
5/7/20203/31/2020($0.79)($0.69)+$0.10($0.69)$6.73 million$5.70 million  
2/26/2020Q4$0.35($0.74)($1.09)($0.74)$50.65 million$12.28 million  
11/12/2019Q3 2019($0.73)($0.66)+$0.07($0.66)$4.72 million$3.90 million  
8/6/2019Q2 2019($0.59)($0.69)($0.10)($0.69)$6.88 million$2.33 million  
5/7/20193/31/2019($0.57)($0.60)($0.03)($0.60)$7.62 million$2.07 million  
2/28/2019Q4 2018($0.48)($0.52)($0.04)($0.52)$16.30 million$6.12 million
11/7/20189/30/2018($0.72)($0.32)+$0.40($0.32)$9.83 million$14.52 million  
8/6/2018Q2 2018($0.67)($0.82)($0.15)($0.82)$7.01 million$7.37 million
5/3/2018Q1 2018($0.82)($0.67)+$0.15($0.67)$4.04 million$3.90 million
3/6/2018Q4 2017($0.75)($0.84)($0.09)($0.84)$4.25 million$3.70 million
11/7/2017Q3 2017($0.60)($0.64)($0.04)($0.64)$2.66 million$6.28 million
8/9/2017Q2 2017($0.64)($0.65)($0.01)($0.65)$2.20 million$3.10 million  
5/15/2017Q1 2017($0.62)($0.85)($0.23)($0.85)$1.00 million$0.68 million
3/7/2017Q4 2016($0.6220)($1.10)($0.4780)($1.10)$1.11 million$0.90 million  
11/7/2016Q3($0.6380)($0.59)+$0.0480($0.59)$1.00 million$1.00 million  
8/9/2016Q2($0.54)($0.54)($0.54)$3.52 million$3.39 million  
5/16/2016Q116($0.23)($0.80)($0.57)($0.80)$1.08 million$0.80 million  
3/30/2016Q4($0.52)($4.05)($3.53)($4.05)$0.79 million












Editas Medicine Earnings - Frequently Asked Questions

When is Editas Medicine's earnings date?

Editas Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 3rd, 2022 based off last year's report dates. Learn more on EDIT's earnings history.

Did Editas Medicine beat their earnings estimates last quarter?

In the previous quarter, Editas Medicine (NASDAQ:EDIT) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.81) by $0.07. Learn more on analysts' earnings estimate vs. EDIT's actual earnings.

How can I listen to Editas Medicine's earnings conference call?

The conference call for Editas Medicine's latest earnings report can be listened to online. Listen to Conference Call

How can I read Editas Medicine's conference call transcript?

The conference call transcript for Editas Medicine's latest earnings report can be read online. Read Transcript

How much revenue does Editas Medicine generate each year?

Editas Medicine (NASDAQ:EDIT) has a recorded annual revenue of $25.54 million.

How much profit does Editas Medicine generate each year?

Editas Medicine (NASDAQ:EDIT) has a recorded net income of -$192.50 million. EDIT has generated -$2.73 earnings per share over the last four quarters.

What is Editas Medicine's EPS forecast for next year?

Editas Medicine's earnings are expected to grow from ($3.41) per share to ($3.38) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:EDIT) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.